Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) closed at $232.27 down -1.40% from its previous closing price of $235.56. In other words, the price has decreased by -$1.40 from its previous closing price. On the day, 1.53 million shares were traded. ALNY stock price reached its highest trading level at $242.49 during the session, while it also had its lowest trading level at $229.855.
Ratios:
For a deeper understanding of Alnylam Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.84 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1703.75. For the most recent quarter (mrq), Quick Ratio is recorded 2.69 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 84.27 whereas as Long-Term Debt/Eq ratio is at 80.17.
Goldman Upgraded its Neutral to Buy on August 16, 2024, whereas the target price for the stock was revised from $198 to $370.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 20 ’24 when Greenstreet Yvonne sold 15,000 shares for $280.00 per share. The transaction valued at 4,200,000 led to the insider holds 73,441 shares of the business.
Greenstreet Yvonne bought 15,000 shares of ALNY for $4,200,000 on Aug 20 ’24. On Aug 12 ’24, another insider, Fitzgerald Kevin Joseph, who serves as the CSO & EVP, Head of Research of the company, sold 22,025 shares for $270.99 each. As a result, the insider received 5,968,516 and left with 12,881 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALNY now has a Market Capitalization of 29958418432 and an Enterprise Value of 30328702976. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.06 while its Price-to-Book (P/B) ratio in mrq is 924.94. Its current Enterprise Value per Revenue stands at 14.478 whereas that against EBITDA is -229.509.
Stock Price History:
Over the past 52 weeks, ALNY has reached a high of $304.39, while it has fallen to a 52-week low of $141.98. The 50-Day Moving Average of the stock is -15.39%, while the 200-Day Moving Average is calculated to be 10.18%.
Shares Statistics:
For the past three months, ALNY has traded an average of 841.34K shares per day and 964110 over the past ten days. A total of 128.98M shares are outstanding, with a floating share count of 127.95M. Insiders hold about 0.80% of the company’s shares, while institutions hold 96.58% stake in the company. Shares short for ALNY as of 1730332800 were 3697098 with a Short Ratio of 4.39, compared to 1727654400 on 4507154. Therefore, it implies a Short% of Shares Outstanding of 3697098 and a Short% of Float of 3.3000000000000003.
